PCRX PACIRA BIOSCIENCES
Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about PACIRA BIOSCIENCES: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
10 rated views · 11 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 13 reports on PCRX from 11 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target, 1 lowered it, 1 left it unchanged and 4 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 3 downgrades.
Latest observed target change: HC Wainwright lowered its target from $38.00 (set 1 Jul 2026) to $36.50 on 9 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| H.C. Wainwright | Douglas Tsao | Hold | 9 Oct 2026 | 36.50 USD |
| Jefferies | Dennis Ding | Hold | 8 Oct 2026 | 36.00 USD |
| Jefferies | Glen Santangelo | Hold | 8 Oct 2026 | 36.00 USD |
| JPMorgan | Hardik Parikh | Hold | 8 Oct 2026 | 36.50 USD |
| Leerink Partners | Daniel Clark | Hold | 9 Sep 2026 | Conflicting reports · excluded |
| Needham | Serge Belanger | Hold | 8 Oct 2026 | — |
| Oppenheimer | Les Sulewski | Buy | 23 Sep 2026 | 32.00 USD |
| RBC Capital Markets | Douglas Miehm | Hold | 9 Oct 2026 | 36.50 USD |
| Truist | Anish Nikhanj | Hold | 9 Oct 2026 | 36.50 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Sell | 5 Oct 2026 | 21.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.